Journal of Clinical Oncology
Standard Journal Abbreviation (ISO4)

Journal of Clinical Oncology
Standard Abbreviation

ISO4 Standard

J. Clin. Oncol.


Journal of Clinical Oncology
Abbreviated Title Table
Full Journal Title Journal Abbreviation
Full Journal Title Journal Abbreviation
Journal of Clinical Oncology
  • J. Clin. Oncol.
  • J CLIN ONCOL
  • Related Journals

    Popular Journals

    Abbreviation of Journal of Clinical Oncology

    The ISO4 abbreviation of Journal of Clinical Oncology is J. Clin. Oncol. . It is the standardised abbreviation to be used for abstracting, indexing and referencing purposes and meets all criteria of the ISO 4 standard for abbreviating names of scientific journals.

    ISO4 Abbreviation of Journal of Clinical Oncology

    (Information and documentation – Rules for the abbreviation of title words and titles of publications) is an international standard, defining a uniform system for the abbreviation of serial publication titles. One major use of ISO 4 is to abbreviate the names of scientific journals. The International Organization for Standardization (ISO) has appointed the ISSN International Centre as the registration authority for ISO 4. It maintains the containing standard abbreviations for words commonly found in serial titles. LTWA includes more than 56,000 words and their abbreviations in 65 languages. In conclusion, under ISO 4 standards, the Journal of Clinical Oncology should be cited as J. Clin. Oncol. for abstracting, indexing and referencing purposes.

    The ISO4 abbreviation of Journal of Clinical Oncology is 
                                        J. Clin. Oncol.
                                    .
    Journal of Clinical Oncology
    Journal Profile
    Journal of Clinical Oncology | Academic Accelerator - About the Journal

    About

    The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer. The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the American Society of Clinical Oncology. It covers research on all aspects of clinical oncology. All articles older than one year are freely available online. The journal was established in 1983 and the editor-in-chief is Stephen A. Cannistra (Harvard Medical School).

    Highly Cited Keywords

    ISSN
    0732-183X
    ISSN

    The ISSN of Journal of Clinical Oncology is 0732-183X . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

    ISSN (Online)
    1527-7755
    ISSN (Online)

    The ISSN (Online) of Journal of Clinical Oncology is 1527-7755 . An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.

    Publisher
    American Society of Clinical Oncology
    Publisher

    Journal of Clinical Oncology is published by American Society of Clinical Oncology .

    Publication Frequency
    Three times a month
    Publication Frequency

    Journal of Clinical Oncology publishes reports Three times a month .

    Coverage
    1983 - Present
    Coverage

    The Publication History of Journal of Clinical Oncology covers 1983 - Present .

    Open Access
    NO
    Open Access

    Journal of Clinical Oncology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.

    Publication Fee
    Publication Fee

    There is no publication fee for submiting manuscript to Journal of Clinical Oncology. Journal of Clinical Oncology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.

    Language
    English
    Language

    The language of Journal of Clinical Oncology is English .

    Country/Region
    United States
    Country/Region

    The publisher of Journal of Clinical Oncology is American Society of Clinical Oncology , which locates in United States .

    Selected Articles

    Full Title Authors
    Full Title Authors
    Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial - 2018 Andrea Gallamini · Corrado Tarella · Simonetta Viviani · Andrea Rossi · Caterina Patti · Antonino Mulè · Marco Picardi · Alessandra Romano · Maria Cantonetti · Giorgio La Nasa · Livio Trentin · Silvia Bolis · Davide Rapezzi · Roberta Battistini · Daniela Gottardi · Paolo Gavarotti · Paolo Corradini · Michele Cimminiello · Corrado Schiavotto · Guido Parvis · Roberta Zanotti · Guido Gini · Andrés J.M. Ferreri · Piera Viero · Maurizio Miglino · Atto Billio · Abraham Avigdor · Alberto Biggi · Federico Fallanca · Umberto Ficola
    Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer - 2018 Megan A. Clarke · Barbara Fetterman · Li C. Cheung · Nicolas Wentzensen · Julia C. Gage · Hormuzd A. Katki · Brian Befano · Maria Demarco · John Schussler · Walter Kinney · Tina Raine-Bennett · Thomas Lorey · Nancy E. Poitras · Philip E. Castle · Mark Schiffman
    BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study - 2018 Thomas Kaley · Mehdi Touat · Vivek Subbiah · Antoine Hollebecque · Jordi Rodon · A. Craig Lockhart · Vicki L. Keedy · Franck Bielle · Ralf-Dieter Hofheinz · Florence Joly · Jean-Yves Blay · Ian Chau · Igor Puzanov · Noopur Raje · Jürgen Wolf · Lisa M. DeAngelis · Martina Makrutzki · Todd Riehl · Bethany Pitcher · José Baselga · David M. Hyman
    Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma - 2018 Diwakar Davar · Hong Wang · Joe-Marc Chauvin · Ornella Pagliano · Julien Fourcade · Mignane Ka · Carmine Menna · Amy Rose · Cindy Sander · Amir A. Borhani · Arivarasan Karunamurthy · Ahmad A. Tarhini · Hussein Tawbi · Qing Zhao · Blanca Homet Moreno · Scott Ebbinghaus · Nageatte Ibrahim · John M. Kirkwood · Hassane M. Zarour
    Clinical targeted next-generation sequencing to identify potentially actionable alterations in the majority of Asian cancer patients. - 2018 Song Ling Poon · Yen-Jung Lu · Ren-Shiang Jhou · Yi-Ting Yang · Pei-Ning Yu · Yen-Ting Liu · Yi-Lin Hsieh · Maarja-Liisa Nairismagi · Shu-Jen Chen · Kien Thiam Tan
    Gaps in palliative care provision among the Indian cancer centres. - 2018 Anuja Damani · Jayeeta Chowdhury · Arunangshu Ghoshal · Jayita Deodhar · Mary Ann Muckaden · C.S. Pramesh · Naveen Salins
    Understanding patients’ and family caregivers’ preferences and attitudes towards disclosure of cancer related diagnosis and prognosis. - 2018 Arunangshu Ghoshal · Naveen Salins · Jayita Deodhar · Anuja Damani · Jayeeta Chowdhury · Arundhati Chitre · Mary Ann Muckaden · Rajendra A. Badwe
    Application of a cancer hot-spot panel to guide lung cancer therapy: Asian experience. - 2018 Yi-Ting Yang · Maarja-Liisa Nairismagi · Kai-Che Tung · Yen-Jung Lu · Ren-Shiang Jhou · Pei-Ning Yu · Yen-Ting Liu · Yi-Lin Hsieh · Song Ling Poon · Shu-Jen Chen · Kien Thiam Tan
    Reducing Body Image–Related Distress in Women With Breast Cancer Using a Structured Online Writing Exercise: Results From the My Changed Body Randomized Controlled Trial - 2018 Kerry A. Sherman · Astrid Przezdziecki · Jessica Alcorso · Christopher J. Kilby · Elisabeth Elder · John Boyages · Louise Koelmeyer · Helen Mackie
    Pathogenic Germline BRCA1/2 Mutations and Familial Predisposition to Gastric Cancer - 2018 Hiroshi Ichikawa · Toshifumi Wakai · Masayuki Nagahashi · Yoshifumi Shimada · Takaaki Hanyu · Yosuke Kano · Yusuke Muneoka · Takashi Ishikawa · Kazuyasu Takizawa · Yosuke Tajima · Jun Sakata · Takashi Kobayashi · Hitoshi Kemeyama · Hiroshi Yabusaki · Satoru Nakagawa · Nobuaki Sato · Takashi Kawasaki · Keiichi Homma · Shujiro Okuda · Stephen Lyle · Kazuaki Takabe
    Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial. - 2018 Ghassan K. Abou-Alfa · Tim Meyer · Ann-Lii Cheng · Anthony B. El-Khoueiry · Lorenza Rimassa · Baek-Yeol Ryoo · Irfan Cicin · Philippe Merle · Yen-Hsun Chen · Joong-Won Park · Jean-Frédéric Blanc · Luigi Bolondi · Heinz Josef Klümpen · Stephen L. Chan · Vincenzo Dadduzio · Colin Hessel · Anne E. Borgman-Hagey · Gisela Schwab
    Is cancer associated thrombosis (CAT) a neglected issue? Greek management of thrombosis (GMaT) in cancer patients. - 2018 Nikolaos Tsoukalas · Pavlos Papakotoulas · Athina Christopoulou · Alexandros Ardavanis · Georgios Koumakis · Christos N. Papandreou · George Papatsibas · Pavlos Papakostas · C. Andreadis · Gerasimos Aravantinos · Nikolaos Ziras · Charalambos P. Kalofonos · E. Samantas · Sougleri Maria · Paris Makrantonakis · George Pentheroudakis · Athanasios Athanasiadis · Evangelos Bournakis · Ioannis Varthalitis · Ioannis Boukovinas
    Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: An international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742) - 2018 Brigette Ma · Wan Teck Lim · Boon Cher Goh · Edwin P. Hui · Kwok Wai Lo · Adam Pettinger · Nathan R. Foster · Jonathan W. Riess · Mark Agulnik · Alex Y. Chang · Akhil Chopra · Julie A. Kish · Christine H. Chung · Douglas Adkins · Kevin J. Cullen · Barbara J. Gitlitz · Dean W. Lim · Ka Fai To · K.C. Allen Chan · Y.M. Dennis Lo · Ann D. King · Charles Erlichman · Jun Yin · Brian A. Costello · Anthony T.C. Chan
    T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma - 2018 Jennifer N. Brudno · Irina Maric · Steven D. Hartman · Jeremy J. Rose · Michael Wang · Norris Lam · Maryalice Stetler-Stevenson · Dalia A. Salem · Constance Yuan · Steven Z. Pavletic · Jennifer A. Kanakry · Syed Abbas Ali · Lekha Mikkilineni · Steven A. Feldman · David F. Stroncek · Brenna Hansen · Judith Lawrence · Rashmika Patel · Frances T. Hakim · Ronald E. Gress · James N. Kochenderfer
    Impact of additional cytogenetic abnormalities on clinical outcomes in chronic myeloid leukemia: First report in a Latin American population. - 2018 Christianne Bourlon · Katherinee Morales-Chacon · Aldo Adrian Medina-Acosta · Alvaro Aguayo · Víctor Manuel Anguiano-Álvarez · Maria Teresa Bourlon · Antonio Olivas-Martinez · Elena Tuna-Aguilar
    Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry - 2018 Richard Cathomas · Dirk Klingbiel · Brandon David Bernard · Anja Lorch · Xavier Garcia del Muro · Franco Morelli · Ugo De Giorgi · Mikhail Fedyanin · Christoph Oing · Hege Sagstuen Haugnes · Marcus Hentrich · Christian Fankhauser · Silke Gillessen · Jörg Beyer